Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tabernanthalog Reduces Motivation for Heroin and Alcohol in a Polydrug Use Model
Jasper A. Heinsbroek, Giuseppe Giannotti, J. Alfred Bonilla, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 2, pp. 111-119
Closed Access | Times Cited: 15

Showing 15 citing articles:

Ibogalogs decrease neuropathic pain in mice through a mechanism involving crosstalk between 5-HT2A and mGlu2 receptors
Hugo R. Arias, Laura Micheli, Anders A. Jensen, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117887-117887
Open Access
The Contribution of Psychotherapy in Potential Therapeutic Effects of Psychedelics for Treatment of Opioid Use Disorder
Anahita Bassir Nia, Yalda Farahmand, Gemma M. Griffith, et al.
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access
The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT2A receptor activation
Hugo R. Arias, Deborah Rudin, Dustin J. Hines, et al.
European Journal of Pharmacology (2024) Vol. 966, pp. 176329-176329
Open Access | Times Cited: 4
Psychedelic Therapy: A Primer for Primary Care Clinicians—Ibogaine
Kirsten Cherian, Kenneth Shinozuka, Burton J. Tabaac, et al.
American Journal of Therapeutics (2024) Vol. 31, Iss. 2, pp. e133-e140
Closed Access | Times Cited: 3
Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies
Fahd François Hilal, Jérôme Jeanblanc, Chloé Deschamps, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 5, pp. 525-561
Closed Access | Times Cited: 3
Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABAA receptor and CaV2.2 channel
Han‐Shen Tae, Marcelo O. Ortells, Arsalan Yousuf, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116183-116183
Open Access | Times Cited: 3
Novel psychoplastogen DM506 reduces cue-induced heroin-seeking and inhibits tonic GABA currents in the Prelimbic Cortex
Kassandra Looschen, Shailesh Khatri, Malabika Maulik, et al.
Neurochemistry International (2024) Vol. 178, pp. 105785-105785
Open Access | Times Cited: 3
Non-hallucinogenic compounds derived from iboga alkaloids alleviate neuropathic and visceral pain in mice through a mechanism involving 5-HT2A receptor activation
Hugo R. Arias, Laura Micheli, Deborah Rudin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116867-116867
Open Access | Times Cited: 3
The psychedelic drug DOI reduces heroin motivation by targeting 5-HT2A receptors in a heroin and alcohol co-use model
J. Alfred Bonilla, Giuseppe Giannotti, Nathaniel P. Kregar, et al.
Neuropharmacology (2024) Vol. 261, pp. 110163-110163
Closed Access | Times Cited: 2
Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats
Gabriele Floris, Konrad Dabrowski, Mary Tresa Zanda, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 2
μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
Leah M. Salinsky, Christina R. Merritt, Joshua C. Zamora, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats
Gabriele Floris, Konrad Dabrowski, Mary Tresa Zanda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Emerging GPCR targets for AUD: Insights from preclinical studies
Roberta G. Anversa, Maiya L. Barron, Leigh C. Walker, et al.
Current Opinion in Neurobiology (2024) Vol. 87, pp. 102896-102896
Open Access
The psychoplastogens ibogaminalog and ibogainalog induce antidepressant-like activity in naïve and depressed mice by mechanisms involving 5-HT2A receptor activation and serotonergic transmission
Hugo R. Arias, Deborah Rudin, Dino Luethi, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111217-111217
Closed Access
THE SEROTONIN 5-HT2ARECEPTOR AS AN EVOLVING NEUROTHERAPEUTIC TARGET
Andrew A. Bolinger, Noelle C. Anastasio, Kathryn A. Cunningham, et al.
Medicinal chemistry reviews (2023), pp. 53-81
Closed Access
Page 1

Scroll to top